Melhem Holdings, Inc.

Redefining Global Systems Through Intelligence, Science, and Execution.

A multidisciplinary holding company operating at the convergence of applied artificial intelligence, global health, pharmaceutical access, and institutional strategy — built for system-level impact.

Our Platform Global Initiatives

Scroll

3 Operating Entities

4+ Global Regions

5 Institutional Partners

What We Do

A Global Execution Platform for System-Level Transformation

Melhem Holdings builds, deploys, and scales systems across the sectors that define the trajectory of global health and institutional infrastructure. Our work is not advisory. It is operational — grounded in research, executed through strategy, and measured by long-term impact.

Applied AI

Deploying machine learning and health informatics at the national and institutional scale.

Global Health

Architecting health systems for underserved and high-growth regions across multiple continents.

Pharma Access

Designing pharmaceutical access and distribution infrastructure from clinical to national scale.

Institutional Strategy

Structuring long-term engagements with governments, universities, and global institutions.

Our Platform

Five Entities. One Mandate.

Melhem Scientific

Research & AI Systems

The scientific and intellectual engine of the platform — conducting research in AI-driven health informatics, global health systems, and translational science.

Office of Academic Affairs
AI & Global Health Informatics
External Affairs

Melhem Pharmaceuticals

Access & Clinical Integration

Designing and executing pharmaceutical access strategies — from clinical integration to national supply chain infrastructure across priority markets.

Clinical access architecture
Distribution systems
Pharmaceutical strategy

Melhem Investments LLC

IP, Licensing & Commercialization

The financial and intellectual property holding entity — owning 100% of proprietary assets and structuring licensing, commercialization, and capital partnerships.

Full IP ownership & management
Licensing frameworks
Financial structuring

Melhem Foundation

Philanthropy & Impact

The philanthropic and impact arm of the ecosystem — expanding access to healthcare, education, and opportunity across underserved regions in Lebanon, the Middle East, and Africa.

Medical missions
Student access programs
Capacity building

Melhem Consultancy

Strategy & Execution

The advisory and execution interface of the platform — working with governments and institutions on digital health, AI, and infrastructure strategies that move from design to real deployment.

National digital health strategy
AI & precision health systems
Hospital optimization

Global Reach

Operating Where Impact Is Most Consequential

Melhem Holdings engages at the national and regional level — working alongside governments, ministries, and institutions to build the infrastructure that shapes how populations access health and how systems respond to emerging challenges.

Lebanon

National Digital Health System

An integrated national framework for digitizing health records, clinical data infrastructure, and population health monitoring across the Lebanese health sector.

Africa

Capacity Building & Health Systems

Long-term partnerships across the African continent focused on health workforce development, institutional capacity, and scalable health system architecture.

Institutional Network

Strategic Academic Alignment

Melhem Holdings maintains strategic academic alignment and research engagement with leading global institutions — creating pathways for collaboration, scholarly exchange, and applied research.

Johns Hopkins University

Research Engagement

Harvard Medical School

Academic Alignment

George Washington University

Strategic Collaboration

American University of Beirut

Regional Partnership

Lebanese American University

Academic Network

Leadership

Guided by Vision, Executed with Precision

Nehme Gerges Melhem

President & Group Executive Chairman

Nehme Gerges Melhem is the founding President and Group Executive Chairman of Melhem Holdings, Inc. His work sits at the convergence of applied artificial intelligence, global health infrastructure, and institutional strategy — driving a long-term agenda that spans pharmaceutical access, national digital health systems, and academic engagement across North America, the Middle East, and Africa.

Under his leadership, Melhem Holdings has established itself as a multidisciplinary platform built for the complexity of global system-level transformation — engaging governments, research institutions, and institutional partners to deliver outcomes that are measurable, scalable, and enduring.

Scientific Advisory Board

Bakhos Tannous

Chair, Scientific Advisory Board · PhD

A Harvard Medical School-affiliated researcher of international standing in molecular neuro-oncology and translational biomedical sciences.

Mohamad Z. Koubeissi

Vice Chair, Scientific Advisory Board · MD, MA, FAAN, FANA, FAES

A leading academic neurologist and clinical researcher, bringing institutional depth in translational neuroscience and clinical systems to the advisory framework.